Completed PHASE4 INTERVENTIONAL 2-arm NCT02378350

Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

A Multicenter, Randomized, Open-Label Study of Quality of Life in Peritoneal Dialysis and Conventional In-Center Hemodialysis (ChinaQ Study)

Sponsor: Baxter Healthcare Corporation

Conditions End Stage Renal Disease

Interventions Hemodialysis treatment (no specific device is defined) Peritoneal Dialysis treatment (no specific drug is defined)

Updated 8 times since 2017 Last updated: Mar 11, 2025 Started: Mar 26, 2014 Primary completion: Sep 18, 2017 Completion: Sep 18, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on End Stage Renal Disease, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Apr 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Apr 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Nov 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Aug 2017 — Nov 2017 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Aug 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
Vantive Health LLC

Data source: Vantive Health LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Changsha, China , Chengdu, China , Dalian, China , Fuzhou, China , Guangzhou, China , Guiyang, China , Harbin, China , Lanzhou, China , Nanchang, China , Shanghai, China and 5 more locations